nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTA1—Azathioprine—systemic scleroderma	0.371	0.475	CbGbCtD
Busulfan—GSTM1—Azathioprine—systemic scleroderma	0.213	0.273	CbGbCtD
Busulfan—GSTA2—Azathioprine—systemic scleroderma	0.188	0.241	CbGbCtD
Busulfan—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00492	0.0063	CbGbCtD
Busulfan—GSTM1—artery—systemic scleroderma	0.00475	0.145	CbGeAlD
Busulfan—CYP3A4—Prednisone—systemic scleroderma	0.00393	0.00504	CbGbCtD
Busulfan—GSTM1—blood vessel—systemic scleroderma	0.0037	0.113	CbGeAlD
Busulfan—GSTA1—connective tissue—systemic scleroderma	0.00257	0.0783	CbGeAlD
Busulfan—GSTM1—connective tissue—systemic scleroderma	0.0019	0.0579	CbGeAlD
Busulfan—GSTA1—digestive system—systemic scleroderma	0.00185	0.0566	CbGeAlD
Busulfan—GSTA2—connective tissue—systemic scleroderma	0.00185	0.0565	CbGeAlD
Busulfan—MGST2—lung—systemic scleroderma	0.00182	0.0555	CbGeAlD
Busulfan—GSTM1—skin of body—systemic scleroderma	0.00171	0.0523	CbGeAlD
Busulfan—GSTA1—lung—systemic scleroderma	0.00155	0.0472	CbGeAlD
Busulfan—GSTM1—digestive system—systemic scleroderma	0.00137	0.0418	CbGeAlD
Busulfan—GSTA2—digestive system—systemic scleroderma	0.00134	0.0408	CbGeAlD
Busulfan—GSTP1—connective tissue—systemic scleroderma	0.00119	0.0363	CbGeAlD
Busulfan—GSTM1—lung—systemic scleroderma	0.00114	0.0349	CbGeAlD
Busulfan—GSTA2—lung—systemic scleroderma	0.00112	0.0341	CbGeAlD
Busulfan—GSTP1—smooth muscle tissue—systemic scleroderma	0.00109	0.0332	CbGeAlD
Busulfan—GSTP1—skin of body—systemic scleroderma	0.00107	0.0328	CbGeAlD
Busulfan—GSTP1—digestive system—systemic scleroderma	0.000859	0.0262	CbGeAlD
Busulfan—GSTP1—tendon—systemic scleroderma	0.000817	0.0249	CbGeAlD
Busulfan—GSTP1—lung—systemic scleroderma	0.000717	0.0219	CbGeAlD
Busulfan—CYP3A4—digestive system—systemic scleroderma	0.00035	0.0107	CbGeAlD
Busulfan—Neutropenia—Prednisone—systemic scleroderma	9.32e-05	0.0005	CcSEcCtD
Busulfan—Tachycardia—Lisinopril—systemic scleroderma	9.31e-05	0.0005	CcSEcCtD
Busulfan—Abdominal pain—Azathioprine—systemic scleroderma	9.3e-05	0.000499	CcSEcCtD
Busulfan—Body temperature increased—Azathioprine—systemic scleroderma	9.3e-05	0.000499	CcSEcCtD
Busulfan—Skin disorder—Lisinopril—systemic scleroderma	9.27e-05	0.000497	CcSEcCtD
Busulfan—Diarrhoea—Captopril—systemic scleroderma	9.22e-05	0.000495	CcSEcCtD
Busulfan—Decreased appetite—Mycophenolic acid—systemic scleroderma	9.21e-05	0.000494	CcSEcCtD
Busulfan—Erectile dysfunction—Prednisone—systemic scleroderma	9.18e-05	0.000492	CcSEcCtD
Busulfan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	9.17e-05	0.000492	CcSEcCtD
Busulfan—Feeling abnormal—Leflunomide—systemic scleroderma	9.15e-05	0.000491	CcSEcCtD
Busulfan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	9.15e-05	0.000491	CcSEcCtD
Busulfan—Fatigue—Mycophenolic acid—systemic scleroderma	9.13e-05	0.00049	CcSEcCtD
Busulfan—Nausea—Mometasone—systemic scleroderma	9.11e-05	0.000489	CcSEcCtD
Busulfan—Anorexia—Lisinopril—systemic scleroderma	9.1e-05	0.000488	CcSEcCtD
Busulfan—Gastrointestinal pain—Leflunomide—systemic scleroderma	9.08e-05	0.000487	CcSEcCtD
Busulfan—Weight increased—Prednisone—systemic scleroderma	9.07e-05	0.000487	CcSEcCtD
Busulfan—Pain—Mycophenolic acid—systemic scleroderma	9.06e-05	0.000486	CcSEcCtD
Busulfan—Constipation—Mycophenolic acid—systemic scleroderma	9.06e-05	0.000486	CcSEcCtD
Busulfan—Weight decreased—Prednisone—systemic scleroderma	9.02e-05	0.000484	CcSEcCtD
Busulfan—Hyperglycaemia—Prednisone—systemic scleroderma	8.99e-05	0.000482	CcSEcCtD
Busulfan—Cough—Mycophenolate mofetil—systemic scleroderma	8.94e-05	0.00048	CcSEcCtD
Busulfan—Hypotension—Lisinopril—systemic scleroderma	8.92e-05	0.000478	CcSEcCtD
Busulfan—Dizziness—Captopril—systemic scleroderma	8.91e-05	0.000478	CcSEcCtD
Busulfan—Convulsion—Mycophenolate mofetil—systemic scleroderma	8.88e-05	0.000476	CcSEcCtD
Busulfan—Depression—Prednisone—systemic scleroderma	8.86e-05	0.000475	CcSEcCtD
Busulfan—Hypertension—Mycophenolate mofetil—systemic scleroderma	8.84e-05	0.000474	CcSEcCtD
Busulfan—Urticaria—Leflunomide—systemic scleroderma	8.82e-05	0.000473	CcSEcCtD
Busulfan—Abdominal pain—Leflunomide—systemic scleroderma	8.78e-05	0.000471	CcSEcCtD
Busulfan—Body temperature increased—Leflunomide—systemic scleroderma	8.78e-05	0.000471	CcSEcCtD
Busulfan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	8.73e-05	0.000468	CcSEcCtD
Busulfan—Chest pain—Mycophenolate mofetil—systemic scleroderma	8.72e-05	0.000468	CcSEcCtD
Busulfan—Myalgia—Mycophenolate mofetil—systemic scleroderma	8.72e-05	0.000468	CcSEcCtD
Busulfan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	8.72e-05	0.000468	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	8.69e-05	0.000466	CcSEcCtD
Busulfan—Anxiety—Mycophenolate mofetil—systemic scleroderma	8.69e-05	0.000466	CcSEcCtD
Busulfan—Hypersensitivity—Azathioprine—systemic scleroderma	8.66e-05	0.000465	CcSEcCtD
Busulfan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	8.66e-05	0.000465	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	8.66e-05	0.000465	CcSEcCtD
Busulfan—Insomnia—Lisinopril—systemic scleroderma	8.63e-05	0.000463	CcSEcCtD
Busulfan—Vomiting—Captopril—systemic scleroderma	8.57e-05	0.00046	CcSEcCtD
Busulfan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	8.53e-05	0.000458	CcSEcCtD
Busulfan—Dyspnoea—Lisinopril—systemic scleroderma	8.51e-05	0.000456	CcSEcCtD
Busulfan—Rash—Captopril—systemic scleroderma	8.5e-05	0.000456	CcSEcCtD
Busulfan—Dermatitis—Captopril—systemic scleroderma	8.49e-05	0.000455	CcSEcCtD
Busulfan—Somnolence—Lisinopril—systemic scleroderma	8.48e-05	0.000455	CcSEcCtD
Busulfan—Headache—Captopril—systemic scleroderma	8.44e-05	0.000453	CcSEcCtD
Busulfan—Confusional state—Mycophenolate mofetil—systemic scleroderma	8.43e-05	0.000452	CcSEcCtD
Busulfan—Dyspepsia—Lisinopril—systemic scleroderma	8.4e-05	0.000451	CcSEcCtD
Busulfan—Body temperature increased—Mycophenolic acid—systemic scleroderma	8.37e-05	0.000449	CcSEcCtD
Busulfan—Abdominal pain—Mycophenolic acid—systemic scleroderma	8.37e-05	0.000449	CcSEcCtD
Busulfan—Oedema—Mycophenolate mofetil—systemic scleroderma	8.36e-05	0.000449	CcSEcCtD
Busulfan—Asthma—Methotrexate—systemic scleroderma	8.33e-05	0.000447	CcSEcCtD
Busulfan—Infection—Mycophenolate mofetil—systemic scleroderma	8.31e-05	0.000446	CcSEcCtD
Busulfan—Decreased appetite—Lisinopril—systemic scleroderma	8.3e-05	0.000445	CcSEcCtD
Busulfan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	8.24e-05	0.000442	CcSEcCtD
Busulfan—Fatigue—Lisinopril—systemic scleroderma	8.23e-05	0.000441	CcSEcCtD
Busulfan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	8.2e-05	0.00044	CcSEcCtD
Busulfan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	8.19e-05	0.000439	CcSEcCtD
Busulfan—Hypersensitivity—Leflunomide—systemic scleroderma	8.18e-05	0.000439	CcSEcCtD
Busulfan—Pancreatitis—Methotrexate—systemic scleroderma	8.17e-05	0.000438	CcSEcCtD
Busulfan—Pain—Lisinopril—systemic scleroderma	8.16e-05	0.000438	CcSEcCtD
Busulfan—Constipation—Lisinopril—systemic scleroderma	8.16e-05	0.000438	CcSEcCtD
Busulfan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	8.16e-05	0.000438	CcSEcCtD
Busulfan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	8.12e-05	0.000436	CcSEcCtD
Busulfan—Bradycardia—Prednisone—systemic scleroderma	8.12e-05	0.000436	CcSEcCtD
Busulfan—Diarrhoea—Azathioprine—systemic scleroderma	8.05e-05	0.000432	CcSEcCtD
Busulfan—Haemoglobin—Prednisone—systemic scleroderma	8.02e-05	0.00043	CcSEcCtD
Busulfan—Nausea—Captopril—systemic scleroderma	8e-05	0.000429	CcSEcCtD
Busulfan—Haemorrhage—Prednisone—systemic scleroderma	7.98e-05	0.000428	CcSEcCtD
Busulfan—Anorexia—Mycophenolate mofetil—systemic scleroderma	7.97e-05	0.000428	CcSEcCtD
Busulfan—Asthenia—Leflunomide—systemic scleroderma	7.97e-05	0.000427	CcSEcCtD
Busulfan—Hallucination—Prednisone—systemic scleroderma	7.94e-05	0.000426	CcSEcCtD
Busulfan—Pancytopenia—Methotrexate—systemic scleroderma	7.91e-05	0.000424	CcSEcCtD
Busulfan—Feeling abnormal—Lisinopril—systemic scleroderma	7.86e-05	0.000422	CcSEcCtD
Busulfan—Pruritus—Leflunomide—systemic scleroderma	7.86e-05	0.000421	CcSEcCtD
Busulfan—Connective tissue disorder—Prednisone—systemic scleroderma	7.84e-05	0.000421	CcSEcCtD
Busulfan—Hypotension—Mycophenolate mofetil—systemic scleroderma	7.81e-05	0.000419	CcSEcCtD
Busulfan—Gastrointestinal pain—Lisinopril—systemic scleroderma	7.8e-05	0.000419	CcSEcCtD
Busulfan—Neutropenia—Methotrexate—systemic scleroderma	7.79e-05	0.000418	CcSEcCtD
Busulfan—Dysuria—Methotrexate—systemic scleroderma	7.79e-05	0.000418	CcSEcCtD
Busulfan—Dizziness—Azathioprine—systemic scleroderma	7.78e-05	0.000417	CcSEcCtD
Busulfan—Erectile dysfunction—Methotrexate—systemic scleroderma	7.67e-05	0.000411	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	7.62e-05	0.000409	CcSEcCtD
Busulfan—Asthenia—Mycophenolic acid—systemic scleroderma	7.6e-05	0.000408	CcSEcCtD
Busulfan—Diarrhoea—Leflunomide—systemic scleroderma	7.6e-05	0.000408	CcSEcCtD
Busulfan—Urticaria—Lisinopril—systemic scleroderma	7.58e-05	0.000407	CcSEcCtD
Busulfan—Insomnia—Mycophenolate mofetil—systemic scleroderma	7.56e-05	0.000406	CcSEcCtD
Busulfan—Body temperature increased—Lisinopril—systemic scleroderma	7.54e-05	0.000405	CcSEcCtD
Busulfan—Abdominal pain—Lisinopril—systemic scleroderma	7.54e-05	0.000405	CcSEcCtD
Busulfan—Pruritus—Mycophenolic acid—systemic scleroderma	7.5e-05	0.000402	CcSEcCtD
Busulfan—Vomiting—Azathioprine—systemic scleroderma	7.48e-05	0.000401	CcSEcCtD
Busulfan—Pneumonia—Methotrexate—systemic scleroderma	7.47e-05	0.000401	CcSEcCtD
Busulfan—Eye disorder—Prednisone—systemic scleroderma	7.45e-05	0.0004	CcSEcCtD
Busulfan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	7.45e-05	0.0004	CcSEcCtD
Busulfan—Somnolence—Mycophenolate mofetil—systemic scleroderma	7.43e-05	0.000399	CcSEcCtD
Busulfan—Infestation—Methotrexate—systemic scleroderma	7.43e-05	0.000398	CcSEcCtD
Busulfan—Infestation NOS—Methotrexate—systemic scleroderma	7.43e-05	0.000398	CcSEcCtD
Busulfan—Rash—Azathioprine—systemic scleroderma	7.41e-05	0.000398	CcSEcCtD
Busulfan—Dermatitis—Azathioprine—systemic scleroderma	7.41e-05	0.000397	CcSEcCtD
Busulfan—Depression—Methotrexate—systemic scleroderma	7.4e-05	0.000397	CcSEcCtD
Busulfan—Flushing—Prednisone—systemic scleroderma	7.4e-05	0.000397	CcSEcCtD
Busulfan—Headache—Azathioprine—systemic scleroderma	7.37e-05	0.000395	CcSEcCtD
Busulfan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	7.36e-05	0.000395	CcSEcCtD
Busulfan—Dizziness—Leflunomide—systemic scleroderma	7.34e-05	0.000394	CcSEcCtD
Busulfan—Renal failure—Methotrexate—systemic scleroderma	7.3e-05	0.000392	CcSEcCtD
Busulfan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	7.27e-05	0.00039	CcSEcCtD
Busulfan—Diarrhoea—Mycophenolic acid—systemic scleroderma	7.25e-05	0.000389	CcSEcCtD
Busulfan—Stomatitis—Methotrexate—systemic scleroderma	7.24e-05	0.000388	CcSEcCtD
Busulfan—Angiopathy—Prednisone—systemic scleroderma	7.24e-05	0.000388	CcSEcCtD
Busulfan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000387	CcSEcCtD
Busulfan—Immune system disorder—Prednisone—systemic scleroderma	7.21e-05	0.000387	CcSEcCtD
Busulfan—Constipation—Mycophenolate mofetil—systemic scleroderma	7.15e-05	0.000384	CcSEcCtD
Busulfan—Pain—Mycophenolate mofetil—systemic scleroderma	7.15e-05	0.000384	CcSEcCtD
Busulfan—Arrhythmia—Prednisone—systemic scleroderma	7.13e-05	0.000382	CcSEcCtD
Busulfan—Haematuria—Methotrexate—systemic scleroderma	7.08e-05	0.00038	CcSEcCtD
Busulfan—Vomiting—Leflunomide—systemic scleroderma	7.06e-05	0.000379	CcSEcCtD
Busulfan—Alopecia—Prednisone—systemic scleroderma	7.05e-05	0.000378	CcSEcCtD
Busulfan—Hypersensitivity—Lisinopril—systemic scleroderma	7.03e-05	0.000377	CcSEcCtD
Busulfan—Hepatobiliary disease—Methotrexate—systemic scleroderma	7.02e-05	0.000377	CcSEcCtD
Busulfan—Dizziness—Mycophenolic acid—systemic scleroderma	7.01e-05	0.000376	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—systemic scleroderma	7e-05	0.000376	CcSEcCtD
Busulfan—Rash—Leflunomide—systemic scleroderma	7e-05	0.000376	CcSEcCtD
Busulfan—Dermatitis—Leflunomide—systemic scleroderma	7e-05	0.000375	CcSEcCtD
Busulfan—Mental disorder—Prednisone—systemic scleroderma	6.99e-05	0.000375	CcSEcCtD
Busulfan—Nausea—Azathioprine—systemic scleroderma	6.99e-05	0.000375	CcSEcCtD
Busulfan—Headache—Leflunomide—systemic scleroderma	6.96e-05	0.000373	CcSEcCtD
Busulfan—Erythema—Prednisone—systemic scleroderma	6.94e-05	0.000373	CcSEcCtD
Busulfan—Malnutrition—Prednisone—systemic scleroderma	6.94e-05	0.000373	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—systemic scleroderma	6.93e-05	0.000372	CcSEcCtD
Busulfan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	6.89e-05	0.00037	CcSEcCtD
Busulfan—Asthenia—Lisinopril—systemic scleroderma	6.85e-05	0.000367	CcSEcCtD
Busulfan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	6.84e-05	0.000367	CcSEcCtD
Busulfan—Pruritus—Lisinopril—systemic scleroderma	6.75e-05	0.000362	CcSEcCtD
Busulfan—Vomiting—Mycophenolic acid—systemic scleroderma	6.74e-05	0.000361	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—systemic scleroderma	6.7e-05	0.000359	CcSEcCtD
Busulfan—Rash—Mycophenolic acid—systemic scleroderma	6.68e-05	0.000358	CcSEcCtD
Busulfan—Dermatitis—Mycophenolic acid—systemic scleroderma	6.67e-05	0.000358	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—systemic scleroderma	6.67e-05	0.000358	CcSEcCtD
Busulfan—Urticaria—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000356	CcSEcCtD
Busulfan—Headache—Mycophenolic acid—systemic scleroderma	6.64e-05	0.000356	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—systemic scleroderma	6.62e-05	0.000355	CcSEcCtD
Busulfan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	6.61e-05	0.000355	CcSEcCtD
Busulfan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.61e-05	0.000355	CcSEcCtD
Busulfan—Nausea—Leflunomide—systemic scleroderma	6.6e-05	0.000354	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—systemic scleroderma	6.58e-05	0.000353	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—systemic scleroderma	6.54e-05	0.000351	CcSEcCtD
Busulfan—Diarrhoea—Lisinopril—systemic scleroderma	6.53e-05	0.00035	CcSEcCtD
Busulfan—Anaemia—Prednisone—systemic scleroderma	6.42e-05	0.000344	CcSEcCtD
Busulfan—Agitation—Prednisone—systemic scleroderma	6.38e-05	0.000342	CcSEcCtD
Busulfan—Dizziness—Lisinopril—systemic scleroderma	6.31e-05	0.000338	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—systemic scleroderma	6.3e-05	0.000338	CcSEcCtD
Busulfan—Nausea—Mycophenolic acid—systemic scleroderma	6.29e-05	0.000338	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—systemic scleroderma	6.23e-05	0.000334	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—systemic scleroderma	6.19e-05	0.000332	CcSEcCtD
Busulfan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	6.16e-05	0.00033	CcSEcCtD
Busulfan—Vomiting—Lisinopril—systemic scleroderma	6.07e-05	0.000325	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—systemic scleroderma	6.05e-05	0.000324	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—systemic scleroderma	6.02e-05	0.000323	CcSEcCtD
Busulfan—Rash—Lisinopril—systemic scleroderma	6.02e-05	0.000323	CcSEcCtD
Busulfan—Convulsion—Prednisone—systemic scleroderma	6.02e-05	0.000323	CcSEcCtD
Busulfan—Dermatitis—Lisinopril—systemic scleroderma	6.01e-05	0.000322	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—systemic scleroderma	6.01e-05	0.000322	CcSEcCtD
Busulfan—Asthenia—Mycophenolate mofetil—systemic scleroderma	6e-05	0.000322	CcSEcCtD
Busulfan—Hypertension—Prednisone—systemic scleroderma	6e-05	0.000322	CcSEcCtD
Busulfan—Chills—Methotrexate—systemic scleroderma	5.98e-05	0.000321	CcSEcCtD
Busulfan—Headache—Lisinopril—systemic scleroderma	5.98e-05	0.000321	CcSEcCtD
Busulfan—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.92e-05	0.000317	CcSEcCtD
Busulfan—Arthralgia—Prednisone—systemic scleroderma	5.91e-05	0.000317	CcSEcCtD
Busulfan—Myalgia—Prednisone—systemic scleroderma	5.91e-05	0.000317	CcSEcCtD
Busulfan—Anxiety—Prednisone—systemic scleroderma	5.89e-05	0.000316	CcSEcCtD
Busulfan—Alopecia—Methotrexate—systemic scleroderma	5.89e-05	0.000316	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	5.87e-05	0.000315	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—systemic scleroderma	5.84e-05	0.000313	CcSEcCtD
Busulfan—Erythema—Methotrexate—systemic scleroderma	5.8e-05	0.000311	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—systemic scleroderma	5.8e-05	0.000311	CcSEcCtD
Busulfan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.72e-05	0.000307	CcSEcCtD
Busulfan—Nausea—Lisinopril—systemic scleroderma	5.67e-05	0.000304	CcSEcCtD
Busulfan—Oedema—Prednisone—systemic scleroderma	5.67e-05	0.000304	CcSEcCtD
Busulfan—Infection—Prednisone—systemic scleroderma	5.63e-05	0.000302	CcSEcCtD
Busulfan—Back pain—Methotrexate—systemic scleroderma	5.61e-05	0.000301	CcSEcCtD
Busulfan—Nervous system disorder—Prednisone—systemic scleroderma	5.56e-05	0.000298	CcSEcCtD
Busulfan—Tachycardia—Prednisone—systemic scleroderma	5.53e-05	0.000297	CcSEcCtD
Busulfan—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.53e-05	0.000297	CcSEcCtD
Busulfan—Skin disorder—Prednisone—systemic scleroderma	5.5e-05	0.000295	CcSEcCtD
Busulfan—Anorexia—Prednisone—systemic scleroderma	5.4e-05	0.00029	CcSEcCtD
Busulfan—Anaemia—Methotrexate—systemic scleroderma	5.36e-05	0.000288	CcSEcCtD
Busulfan—Vomiting—Mycophenolate mofetil—systemic scleroderma	5.32e-05	0.000285	CcSEcCtD
Busulfan—Rash—Mycophenolate mofetil—systemic scleroderma	5.27e-05	0.000283	CcSEcCtD
Busulfan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.27e-05	0.000283	CcSEcCtD
Busulfan—Headache—Mycophenolate mofetil—systemic scleroderma	5.24e-05	0.000281	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—systemic scleroderma	5.19e-05	0.000279	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.16e-05	0.000277	CcSEcCtD
Busulfan—Insomnia—Prednisone—systemic scleroderma	5.13e-05	0.000275	CcSEcCtD
Busulfan—Cough—Methotrexate—systemic scleroderma	5.06e-05	0.000272	CcSEcCtD
Busulfan—Convulsion—Methotrexate—systemic scleroderma	5.03e-05	0.00027	CcSEcCtD
Busulfan—Dyspepsia—Prednisone—systemic scleroderma	4.99e-05	0.000268	CcSEcCtD
Busulfan—Nausea—Mycophenolate mofetil—systemic scleroderma	4.97e-05	0.000266	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—systemic scleroderma	4.94e-05	0.000265	CcSEcCtD
Busulfan—Myalgia—Methotrexate—systemic scleroderma	4.94e-05	0.000265	CcSEcCtD
Busulfan—Chest pain—Methotrexate—systemic scleroderma	4.94e-05	0.000265	CcSEcCtD
Busulfan—Decreased appetite—Prednisone—systemic scleroderma	4.93e-05	0.000264	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	4.91e-05	0.000263	CcSEcCtD
Busulfan—Fatigue—Prednisone—systemic scleroderma	4.89e-05	0.000262	CcSEcCtD
Busulfan—Constipation—Prednisone—systemic scleroderma	4.85e-05	0.00026	CcSEcCtD
Busulfan—Confusional state—Methotrexate—systemic scleroderma	4.78e-05	0.000256	CcSEcCtD
Busulfan—Infection—Methotrexate—systemic scleroderma	4.71e-05	0.000252	CcSEcCtD
Busulfan—Feeling abnormal—Prednisone—systemic scleroderma	4.67e-05	0.000251	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—systemic scleroderma	4.64e-05	0.000249	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—systemic scleroderma	4.64e-05	0.000249	CcSEcCtD
Busulfan—Gastrointestinal pain—Prednisone—systemic scleroderma	4.63e-05	0.000249	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—systemic scleroderma	4.6e-05	0.000247	CcSEcCtD
Busulfan—Anorexia—Methotrexate—systemic scleroderma	4.51e-05	0.000242	CcSEcCtD
Busulfan—Urticaria—Prednisone—systemic scleroderma	4.5e-05	0.000242	CcSEcCtD
Busulfan—Body temperature increased—Prednisone—systemic scleroderma	4.48e-05	0.00024	CcSEcCtD
Busulfan—Abdominal pain—Prednisone—systemic scleroderma	4.48e-05	0.00024	CcSEcCtD
Busulfan—Hypotension—Methotrexate—systemic scleroderma	4.43e-05	0.000237	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.32e-05	0.000231	CcSEcCtD
Busulfan—Insomnia—Methotrexate—systemic scleroderma	4.28e-05	0.00023	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—systemic scleroderma	4.22e-05	0.000227	CcSEcCtD
Busulfan—Somnolence—Methotrexate—systemic scleroderma	4.21e-05	0.000226	CcSEcCtD
Busulfan—Hypersensitivity—Prednisone—systemic scleroderma	4.18e-05	0.000224	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—systemic scleroderma	4.17e-05	0.000224	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—systemic scleroderma	4.12e-05	0.000221	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.09e-05	0.000219	CcSEcCtD
Busulfan—Fatigue—Methotrexate—systemic scleroderma	4.08e-05	0.000219	CcSEcCtD
Busulfan—Asthenia—Prednisone—systemic scleroderma	4.07e-05	0.000218	CcSEcCtD
Busulfan—Pain—Methotrexate—systemic scleroderma	4.05e-05	0.000217	CcSEcCtD
Busulfan—Pruritus—Prednisone—systemic scleroderma	4.01e-05	0.000215	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—systemic scleroderma	3.9e-05	0.000209	CcSEcCtD
Busulfan—Diarrhoea—Prednisone—systemic scleroderma	3.88e-05	0.000208	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.87e-05	0.000208	CcSEcCtD
Busulfan—Urticaria—Methotrexate—systemic scleroderma	3.76e-05	0.000202	CcSEcCtD
Busulfan—Dizziness—Prednisone—systemic scleroderma	3.75e-05	0.000201	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—systemic scleroderma	3.74e-05	0.000201	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—systemic scleroderma	3.74e-05	0.000201	CcSEcCtD
Busulfan—Vomiting—Prednisone—systemic scleroderma	3.6e-05	0.000193	CcSEcCtD
Busulfan—Rash—Prednisone—systemic scleroderma	3.57e-05	0.000192	CcSEcCtD
Busulfan—Dermatitis—Prednisone—systemic scleroderma	3.57e-05	0.000192	CcSEcCtD
Busulfan—Headache—Prednisone—systemic scleroderma	3.55e-05	0.00019	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—systemic scleroderma	3.49e-05	0.000187	CcSEcCtD
Busulfan—Asthenia—Methotrexate—systemic scleroderma	3.4e-05	0.000182	CcSEcCtD
Busulfan—Nausea—Prednisone—systemic scleroderma	3.37e-05	0.000181	CcSEcCtD
Busulfan—Pruritus—Methotrexate—systemic scleroderma	3.35e-05	0.00018	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—systemic scleroderma	3.24e-05	0.000174	CcSEcCtD
Busulfan—Dizziness—Methotrexate—systemic scleroderma	3.13e-05	0.000168	CcSEcCtD
Busulfan—Vomiting—Methotrexate—systemic scleroderma	3.01e-05	0.000162	CcSEcCtD
Busulfan—Rash—Methotrexate—systemic scleroderma	2.99e-05	0.00016	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—systemic scleroderma	2.98e-05	0.00016	CcSEcCtD
Busulfan—Headache—Methotrexate—systemic scleroderma	2.97e-05	0.000159	CcSEcCtD
Busulfan—Nausea—Methotrexate—systemic scleroderma	2.81e-05	0.000151	CcSEcCtD
